November 2 marks a transformative day in healthcare data exchange. Here’s what health information professionals need to know.
Parsing Information Blocking and Interoperability
The final rules on information blocking and interoperability promise significant improvement in health data access and interoperability for every healthcare stakeholder—from patients and providers to technology vendors and payers.
Meeting the basic imperatives of the Cures Act is not the end of a process, however, but the first step in a much longer journey toward an interoperable, person-centered healthcare system.
For our October issue, the Journal of AHIMA publishes a curated collection of articles on implementing the information blocking and interoperability final rules. These articles will equip health information professionals with the necessary resources to adapt to new realities, while also empowering them to provide evidence-based expertise to professionals in every domain of the healthcare ecosystem.
Driven by the pandemic, implementation of remote care technologies has accelerated to an astonishing degree, and there is an increasing number of health systems that are shifting care delivery to alternative care settings including pop-up testing tents and temporary clinics.
Lack of data interoperability in healthcare, with clinical and financial data residing across different systems, has caused extensive challenges for many years. It has also severely hampered the industry’s ability to proactively respond to the COVID-19 pandemic, limiting comorbidity risk identification and personalized treatment therapies.
Even as we all have been experiencing uncertainty, upheavals, and loss from the COVID-19 public health crisis, surprising momentum toward interoperability has occurred in key areas of healthcare delivery.